Gehringer M - Search Results

1

Back in Person: Frontiers in Medicinal Chemistry 2023.

Gehringer M, Pape F, Méndez M, Barbie P, Unzue Lopez A, Lefranc J, Klingler FM, Hessler G, Langer T, Diamanti E, Schiedel M. Gehringer M, et al. ChemMedChem. 2023 Oct 4;18(19):e202300344. doi: 10.1002/cmdc.202300344. Epub 2023 Jul 24. ChemMedChem. 2023. PMID: 37485831

2

Frontiers in Medicinal Chemistry 2022 Goes Virtual.

Diamanti E, Méndez M, Ross T, Kuttruff CA, Lefranc J, Klingler FM, von Nussbaum F, Jung M, Gehringer M. Diamanti E, et al. Among authors: gehringer m. ChemMedChem. 2022 Nov 4;17(21):e202200419. doi: 10.1002/cmdc.202200419. Epub 2022 Oct 5. ChemMedChem. 2022. PMID: 36198574

3

Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes.

Gehringer M, Pfaffenrot E, Bauer S, Laufer SA. Gehringer M, et al. ChemMedChem. 2014 Feb;9(2):277-81. doi: 10.1002/cmdc.201300520. Epub 2014 Jan 8. ChemMedChem. 2014. PMID: 24403205

4

Novel hinge-binding motifs for Janus kinase 3 inhibitors: a comprehensive structure-activity relationship study on tofacitinib bioisosteres.

Gehringer M, Forster M, Pfaffenrot E, Bauer SM, Laufer SA. Gehringer M, et al. ChemMedChem. 2014 Nov;9(11):2516-27. doi: 10.1002/cmdc.201402252. Epub 2014 Aug 19. ChemMedChem. 2014. PMID: 25139757

5

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.

Gehringer M, Laufer SA. Gehringer M, et al. J Med Chem. 2019 Jun 27;62(12):5673-5724. doi: 10.1021/acs.jmedchem.8b01153. Epub 2019 Jan 25. J Med Chem. 2019. PMID: 30565923 Review.

6

Click Chemistry: Novel Applications in Cell Biology and Drug Discovery.

Gehringer M, Laufer SA. Gehringer M, et al. Angew Chem Int Ed Engl. 2017 Dec 4;56(49):15504-15505. doi: 10.1002/anie.201710195. Epub 2017 Oct 25. Angew Chem Int Ed Engl. 2017. PMID: 29068506

7

Covalent inhibitors: back on track?

Gehringer M. Gehringer M. Future Med Chem. 2020 Aug;12(15):1363-1368. doi: 10.4155/fmc-2020-0118. Epub 2020 Jun 29. Future Med Chem. 2020. PMID: 32597212 No abstract available.

8

Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond.

Serafim RAM, Gehringer M, Borsari C. Serafim RAM, et al. Among authors: gehringer m. Pharmaceuticals (Basel). 2024 Feb 5;17(2):206. doi: 10.3390/ph17020206. Pharmaceuticals (Basel). 2024. PMID: 38399421 Free PMC article.

9

Solution-phase parallel synthesis of ruxolitinib-derived Janus kinase inhibitors via copper-catalyzed azide-alkyne cycloaddition.

Gehringer M, Forster M, Laufer SA. Gehringer M, et al. ACS Comb Sci. 2015 Jan 12;17(1):5-10. doi: 10.1021/co500122h. Epub 2014 Dec 1. ACS Comb Sci. 2015. PMID: 25405713

10

tert-Butyl N-[(3R,4R)-1-(2-cyano-acet-yl)-4-methyl-piperidin-3-yl]-N-methyl-carbamate.

Gehringer M, Forster M, Schollmeyer D, Laufer S. Gehringer M, et al. Acta Crystallogr Sect E Struct Rep Online. 2013 May 22;69(Pt 6):o935. doi: 10.1107/S1600536813013512. Print 2013 Jun 1. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 23795101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page